Latest "Global Equipment Market 2015 2019" News Stories

12:32 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Global Equipment Market 2015 2019" found in our extensive news archives from over 250 global news sources.

More Information about Global Equipment Market 2015 2019 on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global Equipment Market 2015 2019 for you to read. Along with our medical data and news we also list Global Equipment Market 2015 2019 Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global Equipment Market 2015 2019 Companies for you to search.

Showing "Global Equipment Market 2015 2019" News Articles 1–25 of 38,000+

Monday 18th March 2019

New Study: Over-the-Counter (OTC) Products Used by Millions of Americans Saves Healthcare System Billions Annually

Cost savings from reduced need for clinical visits and prescription drugs due to OTCs saves U.S. health system $146 billion annually Today, the Consumer Healthcare Products Association (CHPA) released a new study, “Value of OTC Medicines to the U.S. Healthcare System,” that found, on average, each dollar spent on over-the-counter (OTC) medicines sa...

CURE Media Group Named the 2019 Ovarian Cancer Heroes®

CURE Media Group’s flagship product, CURE® magazine, which reaches over a million patients, survivors and caregivers and is dedicated to providing cancer updates, announced the 2019 Ovarian Cancer Heroes® who have made a difference in the field. The event was held during the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer. This...

Frelii Launches New Corporate and Investor Website

Frelii Inc. (OTCQB: FRLI) (“Frelii” or “The Company") today announced that it has launched a new website, which can be visited at The objective with this new interactive website is to provide potential clients, partners and investors an engaging and thoughtful platform to learn about Frelii products, services and solutions while empower...

Canndescent™ Completes the World’s First Commercial Scale Solar Project in Cannabis

Company creates a more sustainable growing model it calls greendoor™, uniting renewable, solar energy with the water-efficiency of indoor growing Cementing its role as an industry trailblazer, Canndescent™ has completed the cannabis industry’s first, commercial-scale solar project, powering its indoor production facility in Desert Hot Springs, CA...

Personalis, Inc. to Present at ICI-IO Combinations Summit 2019

Personalis, Inc., a leader in advanced genomics for precision oncology, today announced that they are scheduled to present at ICI-IO Combinations Summit 2019 in Boston on Wednesday, March 20, 2019 at 2:30 PM, EDT. The presentation, entitled “Challenges and Solutions: Enabling multidimensional tumor immunogenomics for advancing biomarker d...

Los Angeles Conference Brings Together World Leaders in Aesthetic Surgery to Host Most Advanced Aesthetics Industry Event – March 21-24, 2019

Multi-Specialty Cosmetic Academy (MCA), a California-based aesthetic medical educational organization, announces the 2nd Annual LA-MCA Meeting (Los Angeles Multi-Specialty Cosmetic Academy), which will be held March 21-24, 2019, at the Four Seasons Hotel, Doheny Drive, Los Angeles, CA. LA-MCA 2019 is comprised of over 65 leading physician speakers...

Scientists call for moratorium on editing heritable genes

A group of scientists and ethicists, writing in Nature, have called for a global moratorium on all clinical uses of human germline editing to make genetically modified children.1Among those calling...

What’s New in Healthcare? | Infiniti Research Identifies Top Trends and Key Events That Would Redefine the Future of Healthcare

A well-known market intelligence company, Infiniti Research, has announced the completion of their recent article on healthcare industry analysis 2019. This article identifies the top healthcare industry trends and also provides insights into some key events that would revolutionize the future of

HAEMATO AG: Preliminary Results 2018

DGAP-News: HAEMATO AG / Key word(s): Preliminary Results 18.03.2019 / 15:14 The issuer is solely responsible for the content of this announcement. Corporate News of HAEMATO AG: HAEMATO AG was able to achieve an EBITDA of EUR 10.0m for the fiscal year 2018 according to preliminary IFRS financial statements. HAEMATO AG, Berlin (ISIN: DE0006190705), achieved consolidated sales of EUR 27...

R&D Market Pulse: DOD and Car Companies Shift Funds for R&D

NewsR&D Index member Toyota announced last week that it is increasing its planned U.S. investments by about a third ($4 billion) to $13 billion through 2021.

Attica Bank (TATT) - Balance sheet repair nears completion

Edison Investment Research - Financials - Attica Bank: Through the Artemis and Metexelixis securitisations, Attica’s exposure to impaired loans has reduced significantly and now compares favourably with the larger Greek banks. Management forecasts common equity Tier 1 to increase from 12.2% to 13.2% at year end, representing significant headroom over regulatory requirements. Management will ...

Industry Leaders Launch Healthcare Transparency Initiative (HTI)

Collaboration focused on improving healthcare supply chain to improve patient outcomes SAN FRANCISCO (PRWEB) March 18, 2019 Several leading healthcare companies and providers – including BD Healthcare Solutions, Trinity Health and University of Vermont Health Network, as well as Resilinc, the leading provider of supply chain resiliency intelligence, today announced the launch of the Healthcare ...

USDM Life Sciences Presents Best Practices for Managing GxP Compliance in the Oracle Cloud at Modern Business Experience in Las Vegas

USDM and Oracle are evolving GxP compliance in the cloud. SANTA BARBARA, Calif. (PRWEB) March 18, 2019 For more than 15 years, USDM Life Sciences and Oracle have partnered together to develop solutions that allow life science companies to easily comply with FDA 21 CFR Part 11 and EMA EudraLex Volume 4 Annex 11 regulatory requirements. USDM’s Cloud Assurance™ is a managed service delivering en...

AssuredLeads Launches SaaS Platform

Platform will produce exclusive leads in commercial insurance industry MADISON, Wis. (PRWEB) March 18, 2019 To help commercial insurance agents increase sales production without increasing underwriting expenses, AssuredLeads has launched its SaaS platform, which is designed to assist in every step of the commercial insurance sales process from the agent and broker, to the carrier level. “Havin...

Autism Scholarship Announced by Phoenix Law Firm

Black Wynn, PLLC, a Phoenix personal injury law firm, is pleased to announce that it will be offering a scholarship for those who have been diagnosed with autism. The scholarship award will consist of a $1,000 tuition grant to be paid to the vocational school or college chosen by the winning applicant. PHOENIX (PRWEB) March 18, 2019 Phoenix attorneys David A. Black and William H. Wynn have announ...

White Oak Pediatrics Extends Hours at its Gaithersburg Location

White Oak Pediatrics’ Gaithersburg location will now offer extended hours SILVER SPRING, Md. and GAITHERSBURG, Md. (PRWEB) March 18, 2019 White Oak Pediatrics (, a clinic providing outstanding care for children, adolescents, and youth, is pleased to announce extended hours in its Gaithersburg location (18310 Montgomery Village Ave, Suite 460). Always striving to p...

#TheInventor debuts tonight on @HBOdocs. Here's the review to read: In ‘The Inventor,’ you can’t know Elizabeth Holmes’s secrets. And yet you can’t... … vi

#TheInventor debuts tonight on @HBOdocs. Here's the review to read: In ‘The Inventor,’ you can’t know Elizabeth Holmes’s secrets. And yet you can’t... … via @statnews @damiangarde

Diagnostics Data Analytics Company Diaceutics to List on London Stock Exchange

Company seeking £53M IPO on London Stock Exchange junior market, AIM (Alternative Investment Market) Diaceutics expects the addressable market for its specific services to grow to US$2.5BN by 2023 Diaceutics plc, a revenue-generating and profitable diagnostics data analytics and implementation services company which ...

Pharma industry venture financing deals in February 2019 total $1.7bn globally

Total pharma industry venture financing deals in February 2019 worth $1.7bn were announced globally, according to GlobalData’s deals database. Embed...Read More... The post Pharma industry venture financing deals in February 2019 total $1.7bn globally appeared first on Pharmaceutical Technology.

Pharma industry M&A deals in February 2019 total $28.83bn globally

Total pharma industry M&A deals in February 2019 worth $28.83bn were announced globally, according to GlobalData’s deals database. Embed this...Read More... The post Pharma industry M&A deals in February 2019 total $28.83bn globally appeared first on Pharmaceutical Technology.

Sterna Biologicals holds Scientific Advisory Board meeting at 14th Congress of ECCO to advance phase IIb clinical development program of SB012 in Ulcerative Colitis

DGAP-News: sterna biologicals GmbH & Co. KG / Key word(s): Miscellaneous 18.03.2019 / 14:00 The issuer is solely responsible for the content of this announcement. STERNA BIOLOGICALS HOLDS SCIENTIFIC ADVISORY BOARD MEETING AT 14th CONGRESS OF ECCO TO ADVANCE PHASE IIb CLINICAL DEVELOPMENT PROGRAM OF SB012 IN ULCERATIVE COLITIS Meeting included international key opinion leaders Inpu...

My Gene Counsel and Ambry Genetics Join Forces to Bridge the Gap Between Direct-to-Consumer Testing and Medical-Grade Genetic Testing

The One-Stop Solution Will Allow Direct-to-Consumer Kit Users to Confirm Their Hereditary Cancer Results NEW HAVEN, Conn. (PRWEB) March 18, 2019 My Gene Counsel, a digital health company that provides personalized, easy-to-understand genetic testing reports, today announced a partnership with Ambry Genetics to offer the first One-Stop Solution for direct-to-consumer (DTC) genetic test results con...

Clinipace Selects TransPerfect’s Trial Interactive E-Feasibility and eTMF Solutions to Support Future Studies

TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Clinipace has selected TransPerfect’s

Aerpio Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial

Aerpio Pharmaceuticals acknowledged the failure of its lead pipeline candidate in a Phase IIb trial in patients with moderate to severe non-proliferative diabetic retinopathy (NPDR), triggering a selloff by investors that sent the company’s shares plunging by more than 70% in early market trading. AKB-9778 failed the Phase IIb TIME-2b trial (NCT03197870) by missing its […] The post Aerpio ...

Edison initiates coverage on Actinogen Medical (ACW)

Edison Investment Research Limited 18-March-2019 / 12:33 GMT/BST London, UK, 18 March 2019 Edison initiates coverage on Actinogen Medical (ACW) Actinogen Medical is an ASX-listed Australian biotech developing its lead asset Xanamem to treat cognitive impairment that occurs in chronic neurodegenerative diseases. Xanamem(R) is a selective 11β-HSD1 inhibitor that is able to cross the bloo...

Quick Search


News Quicklinks